Biospective Inc. is a specialty Contract Research Organization (CRO) with particular strengths in CNS diseases and disorders, including Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, ALS, Schizophrenia, and Depression. Our unique, state-of-the-art technologies and world-class scientific pre-clinical and clinical expertise accelerates the drug discovery timeline. Biospective provides industry-leading services in several cores areas: animal models and behavioral assays; animal imaging (NIGHTWING™ Platform), histology, and quantitative IHC (PERMITS™ Platform); and human MRI, fMRI, PET, and SPECT imaging (PIANO™ Platform). These platforms represent some of Biospective’s fully-automated, unbiased, and high-throughput technologies that provide sponsors with an unparalleled ability to assess the efficacy of their novel therapeutic agents throughout preclinical and clinical drug development.

Biotechnology

Clinical Trials

Health Care

Life Sciences

Research

Therapeutics

Biospective Inc.

Biospective Inc.'s headquarters in Montreal, Canada

This department oversees the planning, execution, and delivery of various programs and projects within the organization.

Project Management

This department focuses on advancing knowledge through scientific research and experimentation.

Research and Development

This department focuses on conducting studies, analyzing data, and assisting in various research projects.

Research Division

This department sets the strategic direction and oversees the overall operations of the organization.

People (0)

Jobs (0)

Other teams

Research and Development

Research Division

Executive Leadership